SCHECHTER JONATHAN - Insider Non-Derivative Transactions at PharmaCyte Biotech, Inc. (PMCB) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 12, 2025, SCHECHTER JONATHAN's relationship to PharmaCyte Biotech, Inc. (PMCB) is Director, and currently has 200,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PMCB insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

SCHECHTER JONATHAN - Insider Non-Derivative Transactions of PMCB Common Stock

SCHECHTER JONATHAN - Insider Non-Derivative Transactions at PMCB

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 13, 2025	F -- (Common Stock)	67500	1.02	132500
Dec 13, 2025	Acquisition -- (Common Stock)	150000	0	200000